These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21479319)

  • 41. Nanotoxicology: the molecular science point of view.
    Pumera M
    Chem Asian J; 2011 Feb; 6(2):340-8. PubMed ID: 20725923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Engineered Nanoparticles with Antimicrobial Property.
    Reshma VG; Syama S; Sruthi S; Reshma SC; Remya NS; Mohanan PV
    Curr Drug Metab; 2017; 18(11):1040-1054. PubMed ID: 28952436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative study of predictive computational models for nanoparticle-induced cytotoxicity.
    Sayes C; Ivanov I
    Risk Anal; 2010 Nov; 30(11):1723-34. PubMed ID: 20561263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety assessment of personal care products/cosmetics and their ingredients.
    Nohynek GJ; Antignac E; Re T; Toutain H
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety.
    Nohynek GJ; Lademann J; Ribaud C; Roberts MS
    Crit Rev Toxicol; 2007 Mar; 37(3):251-77. PubMed ID: 17453934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Manufacture and use of nanomaterials: current status in the UK and global trends.
    Aitken RJ; Chaudhry MQ; Boxall AB; Hull M
    Occup Med (Lond); 2006 Aug; 56(5):300-6. PubMed ID: 16868127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toxicological assessment of divalent ion-modified ZnO nanomaterials through artificial intelligence and in vivo study.
    Chandrasekaran K; Kakani V; Kokkarachedu V; Abdulrahman Syedahamed HH; Palani S; Arumugam S; Shanmugam A; Kim S; Kim K
    Aquat Toxicol; 2024 Feb; 267():106826. PubMed ID: 38219502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk management strategy to increase the safety of workers in the nanomaterials industry.
    Ling MP; Lin WC; Liu CC; Huang YS; Chueh MJ; Shih TS
    J Hazard Mater; 2012 Aug; 229-230():83-93. PubMed ID: 22727485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanotechnology: the next big thing, or much ado about nothing?
    Maynard AD
    Ann Occup Hyg; 2007 Jan; 51(1):1-12. PubMed ID: 17041243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An in vitro assessment of panel of engineered nanomaterials using a human renal cell line: cytotoxicity, pro-inflammatory response, oxidative stress and genotoxicity.
    Kermanizadeh A; Vranic S; Boland S; Moreau K; Baeza-Squiban A; Gaiser BK; Andrzejczuk LA; Stone V
    BMC Nephrol; 2013 Apr; 14():96. PubMed ID: 23617532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines.
    Warheit DB; Donner EM
    Nanotoxicology; 2010 Dec; 4():409-13. PubMed ID: 20925448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxicological aspects of long-term treatment of keratinocytes with ZnO and TiO2 nanoparticles.
    Kocbek P; Teskac K; Kreft ME; Kristl J
    Small; 2010 Sep; 6(17):1908-17. PubMed ID: 20677183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. JEM Spotlight: Applications of advanced nanomaterials for environmental monitoring.
    Andreescu S; Njagi J; Ispas C; Ravalli MT
    J Environ Monit; 2009 Jan; 11(1):27-40. PubMed ID: 19137136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Organizing the supervision over the turnover of nanomaterials presenting a potential hazard to human health].
    Onishchenko GG
    Gig Sanit; 2011; (2):4-9. PubMed ID: 21604392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanotechnology and human health: risks and benefits.
    Cattaneo AG; Gornati R; Sabbioni E; Chiriva-Internati M; Cobos E; Jenkins MR; Bernardini G
    J Appl Toxicol; 2010 Nov; 30(8):730-44. PubMed ID: 21117037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Safety assessment of nanomaterials for development of nano-cosmetics].
    Yoshida T; Yoshioka Y; Tsutsumi Y
    Yakugaku Zasshi; 2012; 132(11):1231-6. PubMed ID: 23123712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Research strategies for safety evaluation of nanomaterials, part VII: evaluating consumer exposure to nanoscale materials.
    Thomas T; Thomas K; Sadrieh N; Savage N; Adair P; Bronaugh R
    Toxicol Sci; 2006 May; 91(1):14-9. PubMed ID: 16476686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanotechnology safety concerns revisited.
    Stern ST; McNeil SE
    Toxicol Sci; 2008 Jan; 101(1):4-21. PubMed ID: 17602205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM).
    Westmeier D; Stauber RH; Docter D
    Toxicol Appl Pharmacol; 2016 May; 299():53-7. PubMed ID: 26592323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro assessment of engineered nanomaterials using a hepatocyte cell line: cytotoxicity, pro-inflammatory cytokines and functional markers.
    Kermanizadeh A; Pojana G; Gaiser BK; Birkedal R; Bilanicová D; Wallin H; Jensen KA; Sellergren B; Hutchison GR; Marcomini A; Stone V
    Nanotoxicology; 2013 May; 7(3):301-13. PubMed ID: 22263564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.